Description: ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. The company provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. It offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was incorporated in 1984 and is based in Nagpur, India.
Home Page: www.zimlab.in
B 21 – 22 MIDC Area
Nagpur,
441501
India
Phone:
91 71 1827 1370
Officers
| Name | Title |
|---|---|
| Dr. Anwar Siraj Daud M.Pharm | Executive Chairman & MD |
| Mr. Shyam Mohan Patro | Chief Financial Officer |
| Mr. Piyush Siddheshwar Nikhade | Company Secretary & Compliance Officer |
| Mr. Niraj Pukhraj Dhadiwal | Director of Business Development & Executive Director |
| Mr. Zulfiquar Murtaza Kamal | Director of Finance & Executive Director |
| Mr. Prakash Pralhadrao Sapkal BPharm, MBA | Head of ODS Business, Formulations of Domestic, ROW & Emerging Markets & Director |
| Dr. Chandrashekhar Mainde | CEO & Executive Director |
| Mr. Pradeep Kataria | Senior Vice President of Operations |
| Mr. Vijay Fudke | Senior Vice President of Technical Services |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 36.2628 |
| Price-to-Book MRQ: | 2.4092 |
| Price-to-Sales TTM: | 1.5311 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 556 |